Survey on the treatment reality of patients with Epidermal Growth Factor Receptor (EGFR) mutation-positive non-small cell lung cancer(NSCLC)

Trial Identifier:	D7913R00015
Sponsor:	AstraZeneca
NCTID::	NCT02475720
Start Date:	June 2015
Primary Completion Date:	March 2016
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan, Osaka	Izumi, Osaka, Japan, 594-0071

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.